{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:29:49Z","timestamp":1780154989876,"version":"3.54.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jacc.2020.01.042","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T14:01:59Z","timestamp":1584972119000},"page":"1386-1402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration"],"prefix":"10.1016","volume":"75","author":[{"given":"Guiomar","family":"Mendieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"Ben-Aicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Casani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Ar\u017eanauskait\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Sabate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Vilahur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.01.042_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.01.042_bib2","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.01.042_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2009.05.028","article-title":"Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) randomized trial","volume":"54","author":"Di Sciascio","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.01.042_bib5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.5603\/KP.2016.0157","article-title":"[2016 ESC\/EAS guidelines for the management of dyslipidaemias]","volume":"74","author":"Catapano","year":"2016","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jacc.2020.01.042_bib6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.2018.2444","article-title":"Effect of loading dose of atorvastatin prior to planned percutaneous coronary intervention on major adverse cardiovascular events in acute coronary syndrome: the SECURE-PCI Randomized Clinical Trial","volume":"319","author":"Berwanger","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.01.042_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.CIR.0000136588.62638.5E","article-title":"Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study","volume":"110","author":"Kinlay","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.01.042_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.01.042_bib9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/01.CIR.0000141728.23033.B5","article-title":"High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial","volume":"110","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.01.042_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.01.042_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2014.06.040","article-title":"HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model","volume":"175","author":"Vilahur","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10557-015-6615-4","article-title":"Statin-induced cardioprotection against ischemia-reperfusion injury: potential drug-drug interactions. lesson to be learnt by translating results from animal models to the clinical settings","volume":"29","author":"Birnbaum","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2020.01.042_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2009.02.009","article-title":"Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction","volume":"206","author":"Vilahur","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2020.01.042_bib14","doi-asserted-by":"crossref","first-page":"H3158","DOI":"10.1152\/ajpheart.01354.2006","article-title":"Cardioprotective effect of rosuvastatin in\u00a0vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation","volume":"292","author":"Bulhak","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jacc.2019.05.020","article-title":"Intravenous statin administration during ischemia exerts cardioprotective effects","volume":"74","author":"Mendieta","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-019-0760-z","article-title":"Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia","volume":"115","author":"Mendieta","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jacc.2020.01.042_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.atherosclerosis.2012.07.003","article-title":"Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction","volume":"224","author":"Vilahur","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2020.01.042_bib19","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.116.024014","article-title":"Protective effects of ticagrelor on myocardial injury after infarction","volume":"134","author":"Vilahur","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.01.042_bib20","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.jacc.2015.08.901","article-title":"Hypercholesterolemia abolishes high-density lipoprotein-related cardioprotective effects in the setting of myocardial infarction","volume":"66","author":"Vilahur","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijcard.2009.09.551","article-title":"The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion","volume":"147","author":"Ibanez","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib22","first-page":"338","article-title":"Standardization of cardiac tomographic imaging","volume":"86","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.01.042_bib23","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/cvr\/cvy201","article-title":"P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs","volume":"114","author":"Vilahur","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2020.01.042_bib24","first-page":"826","article-title":"[Reliability of cardiac magnetic resonance imaging indicators of myocardial viability for predicting the recovery of systolic function after a first acute myocardial infarction with a patent culprit artery]","volume":"57","author":"Lopez Lereu","year":"2004","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tem.2014.11.001","article-title":"Is AMPK the savior of the failing heart?","volume":"26","author":"Kim","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jacc.2020.01.042_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1538-7836.2008.03244.x","article-title":"Short-term myocardial ischemia induces cardiac modified C-reactive protein expression and proinflammatory gene (cyclo-oxygenase-2, monocyte chemoattractant protein-1, and tissue factor) upregulation in peripheral blood mononuclear cells","volume":"7","author":"Vilahur","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2020.01.042_bib27","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jacc.2020.01.042_bib28","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2005.11.065","article-title":"Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging","volume":"47","author":"Thiele","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.76.1.44","article-title":"Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction","volume":"76","author":"White","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.01.042_bib30","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2013.11.048","article-title":"Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies","volume":"63","author":"El Aidi","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib31","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1042\/CS20171167","article-title":"Mechanisms contributing to cardiac remodelling","volume":"131","author":"Wu","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2020.01.042_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/jmcc.2002.1533","article-title":"Identification of a novel role for sphingolipid signaling in TNF alpha and\u00a0ischemic preconditioning mediated cardioprotection","volume":"34","author":"Lecour","year":"2002","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2020.01.042_bib33","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1161\/CIRCULATIONAHA.105.581058","article-title":"Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase)","volume":"112","author":"Lecour","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.01.042_bib34","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.108.846105","article-title":"Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction?","volume":"119","author":"Schulz","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.01.042_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cvr\/cvp274","article-title":"Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway","volume":"84","author":"Lacerda","year":"2009","journal-title":"Cardiovasc Res"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720305155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720305155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:32:07Z","timestamp":1760016727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720305155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0735109720305155"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.01.042","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}